Skip to main content
. 2015 Aug 7;94(31):e1284. doi: 10.1097/MD.0000000000001284

FIGURE 3.

FIGURE 3

There was no significant difference in the 3-year overall survival rate between the wild-type KRAS group and the mutant type KRAS group (94.7% vs 92.3%, P = 0.249). KRAS = Kirsten rat sarcoma viral oncogene homolog.